Monoclonal antibody RFT5-ricin chain A conjugate

Drug Profile

Monoclonal antibody RFT5-ricin chain A conjugate

Latest Information Update: 24 Apr 2002

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Antineoplastics; Immunotoxins; Monoclonal antibodies
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Hodgkin's disease

Most Recent Events

  • 20 Jul 2000 Preclinical development for Hodgkin's disease in Germany (Unknown route)
  • 20 Jul 2000 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top